Three phenanthrenes (1-3), four indole alkaloids (4-7) and one steroid (8) were isolated from the leaves of Calanthe arisanensis for the first time. In the antiplatelet aggregation assay, phenanthrenes 1 and 2 showed potential antiplatelet activity. We have reported and discussed here the antiplatelet aggregation properties of the eleven naturally-occurring phenanthrenes (1-2 and 9-17) isolated from the underground part of the plant and eighteen chemically synthesized phenanthrenes (18)(19)(20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(30)(31)(32)(33)(34)(35). Overall, our data demonstrated that 1,4-phenanthrenequinones 20, 21 and 22 (collagen, IC 50 0.2, 0.2, 0.1 µg/mL; thrombin, IC 50 0.8, 1.0, 1.1 µg/mL, respectively) could be promising lead candidates for further cardiovascular disease studies.
Calanthe arisanensis Hayata, an endemic Orchidaceae plant in Taiwan, is distributed from 1000 to 2000 m throughout the island [1] . No phytochemical nor biological studies have been reported except the data in relation to the underground part of this plant [2] [3] [4] . For the aerial part, a MeOH extract of dry leaves of C. arisanensis was partitioned between EtOAc and water to give an EtOAc fraction, which was subjected to silica CC eluting with CHCl 3 -MeOH. After removing a large amount of chlorophyll and fatty acids, eight compounds, including three phenanthrenes, 2,7-dihydroxy-3,5-dimethoxy-9,10-dihydro-phenanthrene (1), 2,7dihydroxy-4-methoxy-9,10-dihydro-phenanthrene (2), densiflorol B (3), four indole alkaloids, tryptanthrin (4), indirubin (5) , isatin (6) , indican (7) and one steroid, (24R)-4α,24-dimethyl-5α-cholesta-7,22dien-3β-ol (8) were isolated ( Figure 1 ).
The structures of the compounds were identified by NMR spectroscopic and MS data interpretation. Compounds 1 and 2 have been found from the roots of this species [3] , but 3-8 were found for the first time in the leaves. All of the isolates, except for 3 and 6, which were isolated in insufficient quantity, were assayed for antiplatelet aggregation activity. Only phenanthrenes 1 and 2 showed potent inhibition of collagen-induced platelet aggregation with IC 50 values of 0.2 and 1.3 g/mL, respectively (Table 1) .
Orchidaceae plants are a main resource of phenanthrenes [5] . Phenanthrenes always possess various biological properties, including cytotoxicity, antiplatelet aggregation and antiinflammatory activity [5] . In our previous studies, eleven naturally occurring phenanthrenes (1-2 and 9-17) were isolated from the roots of C. arisanensis [2, 3] and, additionally, eighteen phenanthrenes (18-35) were synthesized [4] (Figure 2 ). Our studies demonstrated that phenanthrenes are promising compounds for anticancer drug development [2] [3] [4] . In this investigation, 1 and 2 showed potential antiplatelet activity (Table 1) . Therefore, all natural (9-17) and synthesized (18-35) phenanthrene derivatives were subjected to antiplatelet aggregation assay using collagen and thrombin as inducers. As shown in Table 2 , most of the compounds (9-22, 25 and 28-35) showed more potent inhibition against collagen-induced platelet aggregation (IC 50 0.1-41.5 g/mL) than aspirin. However, only 20-22 exhibited significant inhibition against thrombin-induced platelet aggregation with IC 50 values of 0.8, 1.0 and 1.1 g/mL, respectively. Beside, four compounds (11-14) also exhibited moderate effect (IC 50 17.2, 39.6, 34.2, 13.5 g/mL) against platelet aggregation induced by thrombin.
As shown in Figures 1 and 2, phenanthrenes 1-3 have potential antiplatelet activities, especially in the case of collagen-induced aggregation. From the SAR studies of all 1,4-PQs (9-11 and 20-31), 1,4-PQs (11 and 20-22) are more favorable than 3-methoxy-1,4-PQs (9-10 and 23-31) in terms of the inhibition of thrombin-induced platelet aggregation. The 3-methoxy-1,4-PQs were either inactive or only exhibited anti-platelet aggregation when induced by collagen. In general, the lack of an OCH 3 substituent on the quinone ring of 1,4-PQ analogs could be attributed to the antiplatelet aggregation activity. Many plants which contain phenanthrenes have been used in traditional medicine around the world [5] . According to our studies, the phenanthrenes are a promising group of active candidates for antiplatelet activity, especially 20-22, which not only exhibited potent inhibition of collagen, but also thrombin-induced platelet aggregation. The data implied that 20-22 could be potential antiplatelet aggregation lead candidates for the development of new anti-thrombosis agents. Their biological mechanisms have been reported rarely, and we believe they merit further investigation. n-hexane/EtOAc (2:1); 2 mL/min]. Fraction 6 (924.04 mg) was chromatographed over Sephadex LH-20 (CHCl 3 -MeOH 1:1) and then silica gel (CHCl 3 ). Sub-fraction 6-4-7 was purified by HPLC [C 18 ; H 2 O/MeOH (40:60); 3 mL/min] to give 2 (4.12 mg). Fraction 9 (2.85 g) was repeatedly chromatographed on Sephadex LH-20 {CHCl 3 -MeOH (1:1) and EtOAc-MeOH (1:1)}, and sub-fraction 9-5-2 (159.50 mg) was purified by CC over silica gel (CHCl 3 -MeOH 15:1) to yield 6 (1.84 mg). Fraction 11 (6.31 g) was chromatographed using Sephadex LH-20 (MeOH) and then subfraction 11-5 (221.59 mg) was repeatedly chromatographed over silica gel {CHCl 3 -MeOH (7:1) and EtOAc} to yield 7 (16.29 mg).
Antiplatelet aggregation assay:
This assay was carried out according to established protocols [6] .
